Abstract
In chronic lymphatic leukemia (CLL), detection and characterization of prognostic relevant chromosomal alterations is optimally done by interphase-fluorescence in situ hybridization (iFISH). Interphase nuclei derived from blood smears, bone marrow smears or from cultivated and conventionally prepared blood or bone marrow cells can be used. In CLL heterozygous or even homozygous deletion of RB1 can be found. Interestingly an iFISH diagnostic result with RB1 deletion as sole aberration is indicative for a favorable course of the disease. Here we describe the best way how to detect RB1 deletion in CLL.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jan M, Ebert BL, Jaiswal S (2017) Clonal hematopoiesis. Semin Hematol 54:43–50
Shanafelt TD (2009) Predicting clinical outcome in CLL: how and why. Hematology Am Soc Hematol Educ Program 2009:421–429
Bazargan A, Tam CS, Keating MJ (2012) Predicting survival in chronic lymphocytic leukemia. Expert Rev Anticancer Ther 12:393–403
Alhourani E, Rincic M, Othman MA, Pohle B, Schlie C, Glaser A et al (2014) Comprehensive chronic lymphocytic leukemia diagnostics by combined multiplex ligation dependent probe amplification (MLPA) and interphase fluorescence in situ hybridization (iFISH). Mol Cytogenet 7:79
Liehr T, Othman MA, Rittscher K, Alhourani E (2015) The current state of molecular cytogenetics in cancer diagnosis. Expert Rev Mol Diagn 15:517–526
Alhourani E, Aroutiounian R, Harutyunyan T, Glaser A, Schlie C, Pohle B et al (2016) Interphase molecular cytogenetic detection rates of chronic lymphocytic leukemia-specific aberrations are higher in cultivated cells than in blood or bone marrow smears. J Histochem Cytochem 64:495–501
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Liehr, T. (2018). Characterization of RB1 Deletions in Interphase and Metaphase by Molecular Cytogenetics Exemplified in Chronic Lymphatic Leukemia. In: Santiago-Cardona, P. (eds) The Retinoblastoma Protein. Methods in Molecular Biology, vol 1726. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7565-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7565-5_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7564-8
Online ISBN: 978-1-4939-7565-5
eBook Packages: Springer Protocols